Kura Oncology KURA
NASDAQ KURA
$10.65 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kura Oncology (KURA) Gross Profit (2025 - 2026)

Updated

Kura Oncology (KURA) posted Gross Profit of $20.63 million for Q2 2026, up 34.9% from $15.29 million a year earlier and up 14.6% from the prior quarter.

Analysis

Kura Oncology (KURA) Gross Profit (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Profit at Kura Oncology was $68.03 million; for FY2025, it was $67.43 million, up 25.1% from FY2024.

  • In prior years, Kura Oncology's Gross Profit was $53.88 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Kura Oncology 947.36 Mn 947.36 Mn 20.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.63 Mn
Mar 31, 2026 18.00 Mn
Jun 30, 2025 15.29 Mn
Mar 31, 2025 14.11 Mn
API Access

Kura Oncology Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=KURA&period=max&api_key=YOUR_API_KEY